Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,24329,996,2.30 [1.85-2.85],3.743517734622159e-14
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24238,196,3.71 [2.35-5.86],2.0760450947878225e-08
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,26256,193,1.26 [0.78-2.04],0.3534001149441103
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18543,774,2.84 [2.23-3.63],6.406897899164132e-17
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26187,124,0.86 [0.47-1.57],0.6164491593139946
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25118,84,4.08 [2.05-8.11],6.0571444962155866e-05
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27645,123,0.85 [0.46-1.56],0.5944767409799396
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27639,83,0.67 [0.32-1.40],0.2823505380406346
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24485,65,2.91 [1.29-6.54],0.0098263837817999
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,26968,120,3.60 [2.04-6.36],9.730171952830848e-06
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other septicaemia,26919,71,4.11 [1.98-8.54],0.0001510377363255
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27726,78,1.94 [0.93-4.06],0.0786543842171521
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27695,100,1.52 [0.79-2.95],0.2130519363331748
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27690,95,1.51 [0.76-2.98],0.2351522910437821
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Mycoses,27341,62,1.58 [0.69-3.63],0.2824312548138223
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26525,441,2.62 [1.93-3.57],7.457047468799561e-10
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26215,131,3.38 [1.96-5.83],1.2198500502472513e-05
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26389,305,2.69 [1.86-3.87],1.1229567654600237e-07
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",22676,53,1.12 [0.44-2.85],0.8085538511116068
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22687,64,nan [nan-nan],
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",22881,258,nan [nan-nan],
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",22889,266,nan [nan-nan],
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",23302,679,1.29 [0.99-1.69],0.0549439800989492
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22675,52,2.95 [1.25-6.97],0.0136691223581624
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,24845,1036,3.10 [2.51-3.82],2.658082897846318e-26
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26640,296,0.93 [0.63-1.38],0.7286015521368046
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27380,111,0.89 [0.47-1.70],0.7325124368084228
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27824,90,1.02 [0.50-2.07],0.95501354116292
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Rectum,27599,59,1.60 [0.68-3.74],0.2809800976572629
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27822,69,0.76 [0.34-1.73],0.520171024310045
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Stomach,27870,54,0.75 [0.30-1.89],0.5414265662164263
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm,27646,274,1.02 [0.68-1.53],0.9249398468925338
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27820,109,1.58 [0.84-2.97],0.1563960325564811
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27818,106,0.92 [0.48-1.78],0.8142656041576358
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27749,69,0.81 [0.36-1.84],0.6208705999614853
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Haemangioma, any site",27750,68,0.76 [0.33-1.73],0.5160092471409202
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Melanocytic naevi,27653,268,0.87 [0.57-1.32],0.5080291486346531
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,27829,121,0.82 [0.45-1.53],0.5389910340906816
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Other benign neoplasms of skin,27718,230,1.57 [1.01-2.42],0.043630610413907
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm of breast,27806,139,1.10 [0.62-1.96],0.7350044297842664
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Leiomyoma of uterus,27296,996,0.83 [0.67-1.03],0.0981491226244689
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26441,271,2.95 [2.00-4.35],4.917988209888769e-08
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26171,454,2.60 [1.91-3.53],1.3778070269575675e-09
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26171,454,2.60 [1.91-3.53],1.3778070269575675e-09
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),24610,420,2.01 [1.45-2.79],3.2060906427280064e-05
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27291,100,1.95 [1.00-3.79],0.0493032091740531
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27519,106,1.60 [0.84-3.02],0.1513175095966626
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23092,923,2.21 [1.77-2.77],4.192327158613041e-12
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,25520,906,1.91 [1.53-2.39],1.250414426448036e-08
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,25998,123,3.73 [2.12-6.57],5.2462820506593575e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26855,61,4.17 [2.00-8.68],0.00013356313003
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25985,110,3.88 [2.14-7.02],7.519678409401574e-06
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26293,418,4.48 [3.29-6.10],1.867883931719724e-21
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26283,408,4.33 [3.16-5.92],5.0108256953496356e-20
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,25762,199,1.23 [0.75-2.02],0.4066309695828588
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",25765,196,1.27 [0.77-2.09],0.3470740914728895
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22895,726,1.96 [1.52-2.53],2.025357187677246e-07
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22252,83,1.61 [0.78-3.34],0.1978672101406219
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,22841,672,1.94 [1.49-2.52],7.886032954947653e-07
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22220,51,2.32 [0.94-5.71],0.0667176809654928
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",22239,70,1.69 [0.77-3.73],0.1941802809030255
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Any mental disorder,23491,625,2.34 [1.80-3.05],2.756151118553378e-10
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",22985,119,3.69 [2.10-6.46],5.319476885244285e-06
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27625,81,2.33 [1.16-4.67],0.0172088061419751
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27666,49,3.16 [1.34-7.44],0.0083700325145547
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,26403,39,1.65 [0.58-4.75],0.3498996028019334
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",27821,39,1.49 [0.52-4.26],0.4596167672975485
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",22905,39,1.76 [0.61-5.04],0.2921052972453882
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Alcohol dependence,26390,26,6.34 [2.24-17.94],0.000503457169594
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Smoking dependency,26280,34,5.39 [2.23-13.04],0.0001827599913139
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22909,43,1.66 [0.61-4.50],0.3192154042963884
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",23254,388,2.58 [1.86-3.57],1.4611324010951582e-08
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Depression,25845,345,2.45 [1.73-3.45],3.5367229801032426e-07
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Depression or dysthymia,23032,303,2.57 [1.78-3.72],4.793477242682915e-07
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",23017,151,1.95 [1.15-3.31],0.0137927077182616
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Other anxiety disorders,25928,78,1.92 [0.93-3.96],0.0757667752293954
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Neurological diseases,24014,1647,1.82 [1.54-2.16],3.2028385540662217e-12
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,21952,183,3.04 [1.90-4.87],3.526890230580948e-06
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27671,152,3.01 [1.82-5.00],1.978919404657457e-05
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26511,425,2.05 [1.49-2.81],8.358791917736e-06
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Epilepsy,26225,139,3.94 [2.35-6.59],1.821826686501784e-07
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Migraine,26212,126,1.85 [1.03-3.33],0.0389065059902558
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27421,117,1.62 [0.88-2.99],0.1195762276228351
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27163,59,0.82 [0.34-1.95],0.6511789153823441
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other sleep disorders,26183,97,1.51 [0.78-2.91],0.2188873432785741
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Sleep apnoea,27444,68,1.48 [0.68-3.23],0.3222687619025067
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26473,868,1.31 [1.04-1.65],0.0199384983596383
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25728,123,2.20 [1.23-3.91],0.0074525106426622
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26158,553,1.07 [0.80-1.43],0.6401040275223924
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27608,77,3.08 [1.54-6.19],0.0015412203277413
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Hemiplegia,27588,57,3.76 [1.71-8.24],0.0009570665271875
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other neurological diseases,27373,125,2.06 [1.15-3.68],0.0146938505031274
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27118,428,1.23 [0.89-1.70],0.218640098789695
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,26941,251,1.11 [0.73-1.69],0.6293712104210092
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26762,72,1.37 [0.62-3.03],0.4299146515396306
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26825,135,1.07 [0.60-1.90],0.821928722234109
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26795,105,1.32 [0.69-2.52],0.4047961269151094
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23678,180,1.38 [0.84-2.29],0.2048775188789574
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23915,417,1.62 [1.17-2.26],0.0038967713519849
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,26810,185,0.96 [0.58-1.58],0.8761282381824959
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27598,34,4.21 [1.54-11.51],0.0051290129438107
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1800,34,1.41 [0.50-3.98],0.5175257083558878
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",25832,34,4.92 [1.81-13.37],0.0017659526322678
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27154,96,1.36 [0.69-2.70],0.377489438129747
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27111,53,1.01 [0.40-2.58],0.9806257031906842
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27012,93,2.07 [1.06-4.07],0.0341439488505519
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27283,105,1.84 [0.98-3.46],0.0572898245712939
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,27741,133,1.62 [0.92-2.86],0.0968208691734987
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,27060,105,0.81 [0.42-1.56],0.5212790254545647
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20491,2822,2.00 [1.73-2.32],3.445207686332456e-20
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27279,74,2.36 [1.12-4.96],0.0243012679890349
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21531,2084,1.96 [1.66-2.31],1.2756544251402168e-15
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypertension,21551,2104,1.94 [1.64-2.28],2.643795877133283e-15
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19496,49,1.45 [0.56-3.76],0.4414381614127478
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26155,732,1.78 [1.39-2.28],4.482279061484287e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Angina pectoris,25935,512,1.97 [1.48-2.64],3.7908405217512463e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27190,150,1.90 [1.13-3.20],0.0157801069186548
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27269,229,1.85 [1.21-2.83],0.0045189941489531
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27801,27,2.14 [0.66-6.96],0.2047804037659868
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25520,97,2.16 [1.14-4.08],0.0181708984594976
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,25890,479,1.71 [1.27-2.32],0.0004626566227232
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27068,97,2.38 [1.26-4.52],0.0077634680099869
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27174,217,1.71 [1.10-2.66],0.0164075872286713
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27068,97,1.81 [0.93-3.51],0.0793051057729977
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27068,97,1.81 [0.93-3.51],0.0793051057729977
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19541,94,2.02 [1.02-4.01],0.0434930285117571
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Cardiomyopathy,24200,40,2.45 [0.90-6.62],0.0783783476339061
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Conduction disorders,24240,80,0.92 [0.43-1.96],0.821712580891273
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16712,103,1.21 [0.61-2.41],0.5840078114148712
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16887,278,3.18 [2.15-4.70],6.899506142014153e-09
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other arrhythmias,24212,52,0.66 [0.26-1.69],0.3901447906073715
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,24218,58,1.63 [0.68-3.91],0.2689209163982612
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27014,101,2.71 [1.45-5.06],0.0017123128765041
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27074,128,2.24 [1.28-3.93],0.0049014261585053
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27116,96,1.88 [0.97-3.62],0.0602442489748485
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27188,84,2.20 [1.10-4.40],0.0253406172821292
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26880,72,4.07 [2.06-8.06],5.433069480669863e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26923,115,3.06 [1.73-5.44],0.0001297933362328
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26227,133,1.39 [0.78-2.46],0.2617952885676823
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26202,108,1.79 [0.96-3.34],0.0657324222541949
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27657,105,1.86 [1.00-3.47],0.0511643846565697
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Varicose veins,26710,616,0.93 [0.70-1.23],0.6070919974377099
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypotension,26699,92,2.28 [1.16-4.50],0.0167889992704768
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22637,2127,1.82 [1.56-2.13],2.853432901025532e-14
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27652,128,1.90 [1.07-3.36],0.0275289943943498
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Influenza and pneumonia,26198,205,1.70 [1.07-2.70],0.025584696192795
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26178,185,1.91 [1.17-3.10],0.0091460765055085
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,26949,233,1.52 [0.99-2.34],0.0580376856911579
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,26941,225,1.54 [1.00-2.40],0.052438036003751
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27094,567,1.20 [0.90-1.59],0.208037709589591
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Chronic sinusitis,26642,115,1.77 [0.96-3.26],0.0666067965889912
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Nasal polyp,26607,80,0.53 [0.25-1.10],0.0892841076613213
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26884,357,1.46 [1.03-2.08],0.0326036003384717
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Deviated nasal septum,26667,140,1.76 [1.02-3.06],0.043162774475309
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13415,66,2.78 [1.28-6.06],0.0100978765489383
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,24869,1178,1.67 [1.38-2.04],2.711824725408615e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Early onset COPD,26787,159,1.84 [1.12-3.02],0.0167661977985042
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26807,179,2.14 [1.34-3.40],0.0014117644984637
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",26807,179,2.14 [1.34-3.40],0.0014117644984637
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",25788,1013,1.50 [1.21-1.85],0.0001650470181033
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Asthma,20684,1013,1.77 [1.42-2.20],2.912520128474847e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",20491,1013,1.80 [1.45-2.24],1.24474913331862e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",20670,999,1.81 [1.45-2.25],1.169233892285616e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27535,83,3.27 [1.69-6.33],0.0004284682809501
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Interstitial lung disease,26049,62,6.22 [2.96-13.03],1.3193488731020937e-06
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",27612,62,5.39 [2.66-10.95],3.1448697211868274e-06
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26043,56,7.21 [3.36-15.44],3.77085000284701e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pleural effusion,25995,87,3.91 [2.03-7.54],4.5063384491904697e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other diseases of pleura,26099,191,2.23 [1.39-3.57],0.0008400176242571
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,26684,91,1.44 [0.72-2.87],0.3018099539900625
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19287,6085,1.87 [1.68-2.09],2.709066216873335e-29
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27288,484,1.35 [1.00-1.84],0.0516590414829292
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27826,107,0.85 [0.44-1.63],0.6154536801814601
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Impacted teeth,27831,97,1.04 [0.52-2.07],0.9216685322736834
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Dental caries,26912,108,1.61 [0.86-3.00],0.1334925453735241
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26925,121,1.62 [0.89-2.96],0.1130019418630759
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27816,118,0.91 [0.49-1.71],0.7767050148946946
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26923,119,1.83 [1.01-3.32],0.0452538445212159
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26614,79,1.57 [0.75-3.29],0.226379149993627
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27730,49,1.23 [0.48-3.18],0.6666246941329853
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,21047,223,1.63 [1.05-2.55],0.0296114678051904
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",23165,2341,1.82 [1.57-2.11],1.4624816613479329e-15
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oesophagitis,21113,289,1.69 [1.14-2.50],0.0093081982565438
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21565,741,1.74 [1.36-2.24],1.2437374240742343e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20905,81,1.99 [0.97-4.11],0.061024615046282
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,20960,136,2.14 [1.23-3.75],0.0075539840691632
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20866,42,2.16 [0.78-5.97],0.1372091821629479
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastric ulcer,20973,149,1.90 [1.11-3.26],0.0187477832977575
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Duodenal ulcer,20899,75,0.95 [0.43-2.08],0.897531815664317
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27778,53,0.50 [0.20-1.25],0.1398087900459152
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Chronic gastritis,20960,136,2.24 [1.29-3.89],0.0040751548835695
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21679,855,2.38 [1.90-2.99],8.786141000372543e-14
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of appendix,27704,148,1.20 [0.69-2.09],0.5172240530907034
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Functional dyspepsia,21410,586,1.54 [1.16-2.04],0.0027364678688642
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,21009,185,2.75 [1.71-4.43],3.039568567711488e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27738,142,1.76 [1.02-3.05],0.043473905434224
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute appendicitis,27675,119,1.31 [0.71-2.42],0.3918932197697465
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Hernia,24927,1214,1.79 [1.47-2.17],3.9358227875429894e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Inguinal hernia,23781,68,1.88 [0.85-4.15],0.11746022056188
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Umbilical hernia,23786,73,0.85 [0.39-1.82],0.6677540125804009
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ventral hernia,23823,110,2.17 [1.19-3.96],0.0113993929933744
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24682,969,1.89 [1.53-2.34],6.039520258398083e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26770,927,2.18 [1.76-2.71],1.7947050647377949e-12
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of intestines,22055,2213,1.53 [1.32-1.79],3.2830396585105284e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27511,64,3.26 [1.49-7.16],0.0032244001523785
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",27795,93,2.68 [1.38-5.21],0.003522304980751
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Crohn disease,25936,93,2.80 [1.44-5.45],0.0023136238865101
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25912,69,2.44 [1.12-5.33],0.0244357748173196
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",27716,135,1.79 [1.02-3.15],0.0429642212658931
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ulcerative colitis,25978,135,1.89 [1.07-3.34],0.0279869185982954
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",25964,121,2.50 [1.39-4.49],0.0023226466175707
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26626,783,2.33 [1.84-2.94],1.3690420516222857e-12
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26615,772,2.21 [1.74-2.80],6.930781026661076e-11
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19952,110,1.31 [0.69-2.49],0.4152644207954262
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Intestinal stricture,27385,110,1.19 [0.63-2.25],0.601237781531687
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",19911,69,1.31 [0.58-2.94],0.5178955999737908
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20521,679,1.47 [1.13-1.91],0.0042685847372511
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,20087,245,1.83 [1.20-2.80],0.0052623430221585
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,20234,392,2.36 [1.69-3.29],3.795650385649861e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Constipation,26135,351,2.07 [1.46-2.93],4.471725559484398e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27337,126,1.32 [0.73-2.38],0.3546111855083642
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19967,125,1.84 [1.01-3.34],0.0446354917362558
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19890,48,1.04 [0.39-2.75],0.9338707735934594
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20745,903,1.54 [1.22-1.93],0.0002307729257844
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of intestine,20077,235,1.38 [0.89-2.13],0.1506486316698753
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27320,109,1.21 [0.64-2.28],0.5652269787864441
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of liver,27065,109,,
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of liver,27012,56,9.92 [4.78-20.56],6.946239889601345e-10
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26266,891,2.09 [1.67-2.61],8.505246565517156e-11
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Cholelithiasis,26118,743,2.03 [1.59-2.58],1.2095305010301202e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Cholecystitis,25510,135,2.10 [1.21-3.66],0.0085833570432577
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25444,69,5.38 [2.67-10.85],2.59322762162202e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute pancreatitis,25438,63,2.47 [1.12-5.43],0.0247246236672584
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),27703,63,2.28 [1.03-5.01],0.0413724561719505
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26450,310,2.91 [2.03-4.16],5.363824722784945e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26244,104,5.06 [2.86-8.95],2.4593903314637562e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Coeliac disease,26228,88,5.49 [3.00-10.05],3.347421229276017e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26181,41,2.64 [0.99-7.00],0.05127326326827
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26311,171,2.06 [1.26-3.37],0.0040725439134238
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,GI-bleeding,26301,161,1.91 [1.15-3.19],0.0129851656445596
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,24656,1635,1.45 [1.22-1.73],2.050345607626542e-05
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27396,115,1.40 [0.76-2.59],0.2845854477035976
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27400,463,1.12 [0.82-1.53],0.4935262683877111
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26259,704,1.51 [1.17-1.95],0.0015374611507197
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27025,327,1.65 [1.15-2.36],0.0064597356042054
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26770,72,1.62 [0.75-3.49],0.2201190142973142
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26906,208,1.84 [1.18-2.86],0.0071465823241316
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27573,91,1.81 [0.92-3.56],0.0867791697762667
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27546,64,2.52 [1.15-5.53],0.020770488264376
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27533,51,2.41 [0.99-5.84],0.0520492274612268
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27588,55,1.17 [0.47-2.93],0.739228832786918
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27585,52,1.34 [0.52-3.43],0.5446010130358624
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26996,59,0.74 [0.31-1.75],0.4887330204635279
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27299,362,1.16 [0.81-1.66],0.4063586403981938
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25658,103,1.00 [0.51-1.96],0.9989885460368412
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25710,155,2.34 [1.39-3.95],0.0013899452283802
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25667,112,2.29 [1.24-4.25],0.0084073174864847
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25817,262,1.19 [0.78-1.81],0.4146593013218895
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25791,236,1.27 [0.81-1.97],0.2953103231362749
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19603,4445,1.63 [1.45-1.84],1.7705331861424856e-15
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21380,2557,1.44 [1.24-1.66],9.506984275846554e-07
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25016,1346,1.65 [1.37-1.99],1.0670890300316721e-07
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19038,215,5.64 [3.71-8.56],4.972651436510351e-16
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19354,531,3.01 [2.27-4.01],3.070639319024918e-14
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27275,206,4.88 [3.24-7.34],2.8364647593595195e-14
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27292,188,5.43 [3.57-8.27],3.107034607631704e-15
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20064,1241,1.29 [1.05-1.59],0.0136327689432813
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",22809,1241,1.23 [1.00-1.50],0.0461676777897301
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18835,12,1.84 [0.27-12.34],0.5298738747748822
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27658,12,1.59 [0.25-9.95],0.6228799780446065
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19110,287,1.78 [1.20-2.65],0.0042022415600396
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18911,88,1.86 [0.93-3.75],0.0810831458007206
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19135,312,1.01 [0.68-1.50],0.9592596743281392
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27667,157,1.33 [0.79-2.26],0.2859559477282734
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19308,485,1.15 [0.84-1.57],0.3854222771417486
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19318,495,1.67 [1.23-2.28],0.0010119037085352
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20247,1424,1.29 [1.06-1.55],0.0089766012416296
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18931,108,1.03 [0.53-1.99],0.940951324669074
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19249,426,1.23 [0.88-1.72],0.2338135682000003
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18905,82,0.92 [0.43-1.98],0.8400540766546338
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18930,107,0.86 [0.44-1.66],0.6450431517221671
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19194,371,0.85 [0.60-1.22],0.3867505825001216
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19138,315,0.75 [0.51-1.09],0.1328655379119845
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20768,300,2.05 [1.41-2.99],0.0001928228081923
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27031,224,4.50 [3.00-6.76],3.982316504208027e-13
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,26903,96,5.41 [2.96-9.89],4.0394262799404425e-08
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,23838,83,0.70 [0.33-1.47],0.342936348044636
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,24066,311,1.64 [1.13-2.40],0.0099981163038893
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,24793,1038,1.61 [1.30-1.99],9.89689618223808e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,23974,219,1.53 [0.97-2.40],0.0658541581970581
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,23834,79,0.89 [0.42-1.90],0.7582230045015654
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",24580,825,1.67 [1.32-2.11],2.102772439853235e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23809,54,2.08 [0.86-5.01],0.1023993538993081
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,23999,244,1.45 [0.95-2.23],0.0884727635349444
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,23859,104,1.95 [1.02-3.73],0.0435190665943435
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23847,92,1.53 [0.77-3.05],0.2266569368108045
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,23918,163,1.66 [0.98-2.80],0.0572847950966455
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23832,77,2.91 [1.41-6.00],0.0039376459904037
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,24110,355,1.88 [1.32-2.66],0.0004381026484093
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24059,389,1.51 [1.07-2.12],0.0182311414680584
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23743,73,2.50 [1.20-5.23],0.0147529641788201
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23782,112,2.16 [1.17-3.99],0.0134338343355918
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23814,144,1.02 [0.58-1.79],0.9575093672984928
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23709,39,1.23 [0.42-3.57],0.7091782442475286
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23729,59,2.04 [0.87-4.76],0.099722138406182
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23713,43,1.47 [0.53-4.08],0.4643579454803084
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,23949,279,1.84 [1.24-2.72],0.0022587751020049
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23730,60,1.79 [0.77-4.13],0.1753697265616338
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23738,68,1.66 [0.76-3.65],0.2053880045241634
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23809,139,1.96 [1.13-3.40],0.016940332968496
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23751,81,1.42 [0.68-3.00],0.3523371157487448
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24214,544,1.77 [1.34-2.36],7.328408417210254e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,23862,192,1.11 [0.68-1.79],0.6834786437339964
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,23961,291,1.83 [1.25-2.68],0.0020047076910704
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,25073,236,2.24 [1.46-3.44],0.0002152826722287
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,25323,486,1.82 [1.34-2.47],0.000111787797443
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24878,41,3.27 [1.24-8.59],0.0164174559096332
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,24903,66,1.55 [0.68-3.56],0.3001275465712431
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,24953,116,1.26 [0.67-2.36],0.4793306941963489
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,22725,6192,1.15 [1.04-1.28],0.0071201630743069
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,25367,203,1.00 [0.62-1.62],0.9844776346861228
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25208,44,0.65 [0.23-1.83],0.4161711729199051
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Acute renal failure,25541,37,2.14 [0.75-6.11],0.1572281231662405
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,25551,47,1.51 [0.58-3.95],0.4000974183379134
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25546,42,1.24 [0.44-3.52],0.6797785025186067
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27617,133,1.46 [0.83-2.59],0.1924487580978131
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27492,67,0.76 [0.33-1.71],0.5007448973927264
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27585,101,1.37 [0.71-2.64],0.3521467139485815
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27521,37,1.21 [0.41-3.62],0.7295790431371445
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,25595,1268,1.44 [1.18-1.74],0.0002497517491411
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Cystitis,24465,138,1.31 [0.74-2.32],0.3618525488755111
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,24417,90,1.42 [0.70-2.88],0.3327973937489531
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24496,169,1.44 [0.86-2.41],0.1614328662329798
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Urethral stricture,24417,90,1.23 [0.60-2.50],0.5744354468672005
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,25323,996,1.59 [1.28-1.98],2.416497813861296e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27546,483,0.95 [0.70-1.30],0.751643055397869
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27212,149,0.76 [0.44-1.33],0.3391173637384098
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,27235,172,0.98 [0.59-1.65],0.951960602738556
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27177,114,1.30 [0.70-2.43],0.4107046060554824
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27484,559,0.82 [0.61-1.09],0.1705145815723026
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,27058,133,0.70 [0.39-1.26],0.2385408124039142
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27176,251,0.99 [0.65-1.52],0.9764898319453093
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,25388,4627,1.00 [0.90-1.12],0.9856384772038966
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Endometriosis,21122,361,0.96 [0.67-1.38],0.8352576542850543
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20859,98,1.10 [0.56-2.19],0.7813520579709045
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20924,163,0.88 [0.52-1.48],0.6180748619338727
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21557,796,1.21 [0.95-1.54],0.1231841376121124
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21173,412,1.14 [0.81-1.59],0.4476362103516179
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21733,972,0.69 [0.55-0.86],0.0010283675124585
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Uterine polyps,21082,321,0.59 [0.41-0.86],0.0055105019810036
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21206,445,0.92 [0.67-1.28],0.6298590719499106
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20862,101,0.74 [0.38-1.43],0.3656769858985593
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,20950,189,1.12 [0.68-1.84],0.6467017729392406
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27823,267,1.09 [0.72-1.65],0.6921640478391029
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27835,254,1.17 [0.76-1.79],0.482457902666167
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,27860,141,1.05 [0.59-1.87],0.8631716385370729
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27849,154,1.00 [0.58-1.73],0.9964517595829132
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20908,147,1.58 [0.92-2.72],0.1007596648471403
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20878,117,0.90 [0.48-1.68],0.7470518915140467
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20906,145,0.72 [0.41-1.26],0.2470368785253983
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Irregular menses,27752,472,1.14 [0.84-1.56],0.399014739696398
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",22119,1358,1.14 [0.94-1.38],0.1693918417321485
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21648,887,1.11 [0.88-1.40],0.3657227019563319
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27840,197,0.96 [0.60-1.56],0.8842592137895358
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21231,470,1.17 [0.85-1.60],0.3269097553168205
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,21093,332,0.97 [0.67-1.40],0.8555639258187833
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21670,909,0.96 [0.76-1.20],0.7105017050281843
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Female infertility,20877,116,0.62 [0.34-1.12],0.1162404726674609
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20870,109,0.64 [0.35-1.19],0.1571329822799346
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27858,887,0.84 [0.65-1.09],0.1854933499547874
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27862,1206,0.85 [0.68-1.07],0.1644470275904644
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27859,482,0.73 [0.53-1.01],0.0539572063268312
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,27515,138,0.74 [0.41-1.34],0.3127471108666636
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,27571,194,0.74 [0.46-1.20],0.2258509000417825
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,27544,167,0.55 [0.34-0.91],0.0188063621994511
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",27876,166,1.27 [0.74-2.20],0.3820836595551355
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,27878,163,1.28 [0.74-2.22],0.372119704014196
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,27874,419,0.86 [0.61-1.21],0.3892757620051496
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,27581,126,0.84 [0.45-1.55],0.5743426907636529
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27685,230,1.07 [0.68-1.71],0.7603528141429152
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,27121,150,0.82 [0.46-1.44],0.4801288155000439
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,27174,203,0.76 [0.47-1.23],0.2716026865843869
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,27222,251,1.19 [0.76-1.87],0.4364996797003999
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,27122,151,0.65 [0.38-1.11],0.1156951389412096
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,27110,139,0.53 [0.31-0.89],0.0174261807689824
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,27124,153,0.48 [0.29-0.79],0.0042857229692497
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26888,232,0.64 [0.40-1.02],0.0578209633589618
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],27094,438,0.84 [0.59-1.20],0.3387262867192022
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,27328,672,0.88 [0.65-1.19],0.4012797463708047
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27880,172,0.83 [0.49-1.40],0.4758122431835868
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,26411,131,0.77 [0.42-1.44],0.4196797378119076
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26759,103,0.93 [0.46-1.86],0.8283532740997832
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27887,346,0.67 [0.47-0.98],0.0371548908697963
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27804,263,0.66 [0.43-1.00],0.0507469534008591
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",27874,255,1.01 [0.65-1.56],0.9749824987794878
PLA2G15,Phospholipase A2 group XV,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",27865,246,1.03 [0.66-1.61],0.9069377810221426
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27577,45,0.38 [0.14-0.99],0.0467748213504483
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Falls/tendency to fall,24922,653,1.25 [0.96-1.64],0.1022163547475816
